“Clinical scientists recognize the worth of using the endocannabinoid program in a very trustworthy, Protected way to treat psychiatric conditions, pain management and other professional medical problems,” suggests Dr. Streem."The psychoactive (and probably the toxic) effects of artificial cannabinoid receptor agonists are probably due to their